A Rare Case of Pembrolizumab Associated Encephalopathy.

Authors

Sijan Basnet, Department of Medicine, Reading Hospital-Tower Health, West Reading, PA 19611Follow
Rajanbir Singh
Biswaraj Tharu
Tushar Pawar
Garima Basnet

Document Type

Article

Publication Date

9-9-2022

Abstract

We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by prednisone taper and intravenous immunoglobulin with gradual improvement in his mentation.

Publication Title

J Community Hosp Intern Med Perspect

Volume

12

Issue

5

First Page

57

Last Page

59

Recommended Citation

Basnet, S., Singh, R., Tharu, B., Pawar, T., & Basnet, G. (2022). A Rare Case of Pembrolizumab Associated Encephalopathy.. J Community Hosp Intern Med Perspect, 12 (5), 57-59. https://doi.org/https://doi.org/10.55729%2F2000-9666.1091